IRIS
BUCCI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.855
EU - Europa 5.329
AS - Asia 4.223
Continente sconosciuto - Info sul continente non disponibili 503
SA - Sud America 440
AF - Africa 68
OC - Oceania 6
Totale 17.424
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.698
SG - Singapore 1.795
IT - Italia 1.444
CN - Cina 1.123
IE - Irlanda 581
DE - Germania 527
SE - Svezia 492
UA - Ucraina 487
FR - Francia 465
RU - Federazione Russa 460
VN - Vietnam 394
GB - Regno Unito 389
BR - Brasile 344
TR - Turchia 342
FI - Finlandia 205
IN - India 203
HK - Hong Kong 97
CA - Canada 84
BD - Bangladesh 62
PL - Polonia 54
ES - Italia 44
MX - Messico 43
NL - Olanda 40
AR - Argentina 37
JP - Giappone 29
BE - Belgio 26
ID - Indonesia 24
ZA - Sudafrica 24
MY - Malesia 23
AT - Austria 20
EC - Ecuador 19
IQ - Iraq 19
KR - Corea 15
VE - Venezuela 15
CH - Svizzera 13
IL - Israele 13
IR - Iran 13
CO - Colombia 12
LT - Lituania 12
PK - Pakistan 12
EG - Egitto 11
GR - Grecia 11
TH - Thailandia 10
AL - Albania 9
CZ - Repubblica Ceca 9
EU - Europa 8
KE - Kenya 8
SA - Arabia Saudita 8
JM - Giamaica 7
PH - Filippine 7
UZ - Uzbekistan 7
ET - Etiopia 6
AU - Australia 5
EE - Estonia 5
MA - Marocco 5
PT - Portogallo 5
SI - Slovenia 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
DK - Danimarca 4
LB - Libano 4
PY - Paraguay 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
KZ - Kazakistan 3
MD - Moldavia 3
QA - Qatar 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
BB - Barbados 2
BG - Bulgaria 2
CG - Congo 2
CI - Costa d'Avorio 2
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
RS - Serbia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
LK - Sri Lanka 1
MC - Monaco 1
Totale 16.920
Salva come PNG Salva come JPEG
Città #
Singapore 1.303
San Jose 722
Chandler 721
Jacksonville 568
Dublin 562
Ashburn 488
Dallas 384
Beijing 310
Munich 289
Council Bluffs 269
Princeton 254
Southend 222
Izmir 197
Los Angeles 197
New York 164
The Dalles 163
Santa Clara 158
Nanjing 157
Ho Chi Minh City 136
Ann Arbor 119
Wilmington 111
Pescara 106
Helsinki 104
Hanoi 99
Dearborn 97
Cambridge 93
Chieti 93
Milan 93
Hong Kong 79
Boardman 72
Tongling 70
Nanchang 63
Altamura 62
Rome 62
Moscow 53
São Paulo 51
Houston 49
Buffalo 45
Phoenix 45
Orem 44
Woodbridge 40
Columbus 37
Redondo Beach 37
Shenyang 35
Brooklyn 32
Denver 32
Warsaw 32
Hebei 31
Tianjin 31
Washington 31
Foggia 30
Hefei 27
Chicago 26
London 26
Atlanta 25
Chennai 25
Nuremberg 25
Tokyo 25
Brussels 24
Da Nang 24
Montreal 24
Jinan 23
Frankfurt am Main 22
Toronto 21
Boston 20
Florence 19
Haiphong 19
Kunming 19
Mexico City 19
Poplar 19
Stockholm 19
Bologna 18
Amsterdam 17
Norwalk 17
Johannesburg 16
Manchester 16
Zhengzhou 16
Naples 15
Turku 15
Grevenbroich 14
Hangzhou 14
Rio de Janeiro 14
Seattle 14
Biên Hòa 13
Ningbo 13
Auburn Hills 12
Changsha 12
Jiaxing 12
Mumbai 12
Orange 12
San Francisco 12
Guangzhou 11
Philadelphia 11
Seoul 11
Bari 10
Kraków 10
Kuala Lumpur 10
San Mateo 10
Shanghai 10
Taizhou 10
Totale 10.070
Salva come PNG Salva come JPEG
Nome #
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 560
Comparison between Dutch Lipid Clinic Network (DLCN) criteria, Simon Broome register group (SB) and US MedPed Program diagnostic performance in a pediatric cohort from LIPIGEN study population: preliminary data. 348
MicroRNA profiling in migraine without aura: Pilot study 260
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 257
The diagnostic performance of the Italian Society for the Study of Atherosclerosis (SISA)-modified Dutch Lipid Clinic Network (DLCN) criteria in a pediatric cohort from LIPIGEN study population: preliminary data 232
A unique microRNA signature associated with plaque instability in humans. 213
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 188
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 180
Linee guida cliniche per la prevenzione della cardiopatia ischemica nella ipercolesterolemia familiare: una patologia sotto-diagnosticata e sotto-trattata. Consensus. 175
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 174
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 171
Differences in blood pressure according to body position (supine, Fowler’s and sitting) in hypertensive subjects 170
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 170
VALUTAZIONE FUNZIONALE DELL'ATLETA: RAPPORTI TRA VO2 MAX E COMPOSIZIONE CORPOREA 169
Uneven accuracy of home blood pressure measurement: a multi-centric survey 168
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 168
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers 166
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 162
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 160
A unique microRNA signature associated with ischemic stroke in humans 159
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 159
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 157
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 157
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 154
Ipertensione arteriosa ed algosensibilità muscolare 150
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 148
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 147
Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction. 146
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 146
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 146
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 144
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. 144
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 143
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 142
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 141
A case of coinfection with SARS-Cov-2 and cytomegalovirus in the era of Covid-19. 140
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 139
Risultati immediati ed a lungo termine della rivascolarizzazione coronarica con PTCA con carattere ad autoperfusione vs PTCA con impianto di stent intracoronarico. 139
Association between 5-lipoxygenase expression and plaque instability in humans. 139
COVID-19 and RAS: Unravelling an Unclear Relationship 138
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 138
Improvement of Inflammation and Pain after Three Months’ Exclusion Diet in Rheumatoid Arthritis Patients 138
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 136
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 134
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 134
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 134
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 133
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 132
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 130
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 130
The (K+)ey of the problem 130
[ANALYSIS OF COSTS AND RESULTS OF PROSTAGLANDIN (PGE1 ALPHA-CYCLODESTRIN) THERAPY OF PERIPHERAL ARTERIAL DISEASES] 130
uFollow-Up clinico di un gruppo di pazienti sottoposti a PTCA con impianto di stent intracoronarico. 128
Single coronary artery with a right origin: angiography identification of the R-II subgroup] 128
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 127
DISAGREEMENT AMONG THE MAIN ALGORITHMS FOR CARDIOVASCULAR RISK ESTIMATION IN PATIENTS STRATIFICATION AND IN THEIR CORRELATION WITH ARTERIAL STIFFNESS 127
L’automisurazione domiciliare della pressione: istruzioni per l’uso e sua utilità nel paziente anziano 127
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 126
PROGETTO DI SCREENING SU 24.000 SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI. 126
La stratificazione del rischio di sviluppare Diabete Mellito come strumento di diagnosi precoce: lo studio DIGA 125
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 124
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 124
Impact of hypertension on somatic pain sensitivity in chronic headache 124
Arterial stiffness and global cardiovascular risk: results from a primary prevention population from Abruzzo (Italy) 123
Ensuring Longer Life Study. A new model for an integrated management of patients at high cardiovascular risk. 122
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 121
Cardiovascular risk factor control in common clinical practice in a sample of patients in secondary prevention representative of the Abruzzo population 121
Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia 121
Artrite reumatoide ed aumentato rischio cardiovascolare: impatto delle differenti terapie farmacologiche
 [Rheumatoid arthritis and increased cardiovascular risk: role of the different pharmacological therapies] 120
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 119
HUR protein contributes to modulation of angiotensin ii type 1 receptor expression in human atherosclerotic plaque. 117
Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes 117
HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque. 115
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 115
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 114
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 114
Cholesterol and COVID-19: Findings from lipid profile of patients with SARS-COV-2 infection 114
Cardiovascular risk awareness: what does patient feel? 114
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 113
Effect of evolocumab or ezetimibe added to moderate- Or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: The LAPLACE-2 randomized clinical trial 112
Hypertension modulates miR-145 expression in human atherosclerotic plaques 111
Cost-effectiveness of statins in primary and secondary prevention of cardiovascular event 111
Muscle pain sensitivity in hypertensive patients with and without chronic pain 111
Possible indication of coronary risk trough discriminant functions. 110
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 109
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 109
Long-term positivity to SARS-Cov-2: a clinical case of Covid-19 with persistent evidence of infection 108
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 107
Effects of lifestyle treatment on patients with metabolic syndrome and non-alcoholic hepatic steatosis evaluated with an ultrasonographic and elastographic approach 106
Correlation between Dutch lipid score and genetic diagnosis of FH in pediatric patients 105
An atypical etiology of ARDS: the importance of a careful eye in the evaluation. 104
Endogenous PCSK9 may influence circulating CD45NEG/CD34BRIGHT and CD45NEG/CD34BRIGHT/CD146NEG cells in patients with type 2 Diabetes Mellitus 104
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. 103
PROGETTO DI SCREENING SU 24OOO SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI 103
Effects of the total triterpenic fraction of Centella asiatica in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial 102
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events 102
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 102
Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives 102
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 102
A drug induced autoimmune hemolytic anemia: a case report. 101
Totale 14.258
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.107
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022690 0 0 22 153 39 14 28 39 62 29 122 182
2022/20232.129 165 256 119 223 214 414 130 159 274 44 70 61
2023/20241.188 82 44 75 40 85 333 225 44 35 64 25 136
2024/20252.775 133 449 356 74 103 144 217 158 355 144 299 343
2025/20265.535 485 231 618 705 563 348 939 296 558 441 241 110
2026/2027571 134 304 133 0 0 0 0 0 0 0 0 0
Totale 17.424